BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23370169)

  • 1. Effects of the nitric oxide donor JS-K on the blood-tumor barrier and on orthotopic U87 rat gliomas assessed by MRI.
    Weidensteiner C; Reichardt W; Shami PJ; Saavedra JE; Keefer LK; Baumer B; Werres A; Jasinski R; Osterberg N; Weyerbrock A
    Nitric Oxide; 2013 Apr; 30():17-25. PubMed ID: 23370169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JS-K, a glutathione S-transferase-activated nitric oxide donor with antineoplastic activity in malignant gliomas.
    Weyerbrock A; Osterberg N; Psarras N; Baumer B; Kogias E; Werres A; Bette S; Saavedra JE; Keefer LK; Papazoglou A
    Neurosurgery; 2012 Feb; 70(2):497-510; discussion 510. PubMed ID: 21849924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nitric oxide donor JS-K sensitizes U87 glioma cells to repetitive irradiation.
    Heckler M; Osterberg N; Guenzle J; Thiede-Stan NK; Reichardt W; Weidensteiner C; Saavedra JE; Weyerbrock A
    Tumour Biol; 2017 Jun; 39(6):1010428317703922. PubMed ID: 28653883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth-inhibitory and chemosensitizing effects of the glutathione-S-transferase-π-activated nitric oxide donor PABA/NO in malignant gliomas.
    Kogias E; Osterberg N; Baumer B; Psarras N; Koentges C; Papazoglou A; Saavedra JE; Keefer LK; Weyerbrock A
    Int J Cancer; 2012 Mar; 130(5):1184-94. PubMed ID: 21455987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of nitric oxide on blood-brain barrier integrity and cerebral blood flow in intracerebral C6 gliomas.
    Weyerbrock A; Walbridge S; Saavedra JE; Keefer LK; Oldfield EH
    Neuro Oncol; 2011 Feb; 13(2):203-11. PubMed ID: 21041233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide-releasing prodrug triggers cancer cell death through deregulation of cellular redox balance.
    Maciag AE; Holland RJ; Robert Cheng YS; Rodriguez LG; Saavedra JE; Anderson LM; Keefer LK
    Redox Biol; 2013; 1(1):115-24. PubMed ID: 24024144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JS-K, a glutathione/glutathione S-transferase-activated nitric oxide donor of the diazeniumdiolate class with potent antineoplastic activity.
    Shami PJ; Saavedra JE; Wang LY; Bonifant CL; Diwan BA; Singh SV; Gu Y; Fox SD; Buzard GS; Citro ML; Waterhouse DJ; Davies KM; Ji X; Keefer LK
    Mol Cancer Ther; 2003 Apr; 2(4):409-17. PubMed ID: 12700285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JS-K, a nitric oxide donor, induces autophagy as a complementary mechanism inhibiting ovarian cancer.
    Liu B; Huang X; Li Y; Liao W; Li M; Liu Y; He R; Feng D; Zhu R; Kurihara H
    BMC Cancer; 2019 Jul; 19(1):645. PubMed ID: 31262254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase (COX) Inhibition by Acetyl Salicylic Acid (ASA) Enhances Antitumor Effects of Nitric Oxide in Glioblastoma In Vitro.
    Guenzle J; Garrelfs NWC; Goeldner JM; Weyerbrock A
    Mol Neurobiol; 2019 Sep; 56(9):6046-6055. PubMed ID: 30715649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide prodrugs and metallochemotherapeutics: JS-K and CB-3-100 enhance arsenic and cisplatin cytolethality by increasing cellular accumulation.
    Liu J; Li C; Qu W; Leslie E; Bonifant CL; Buzard GS; Saavedra JE; Keefer LK; Waalkes MP
    Mol Cancer Ther; 2004 Jun; 3(6):709-14. PubMed ID: 15210857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular distribution studies of the nitric oxide-generating antineoplastic prodrug O(2) -(2,4-dinitrophenyl)1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate formulated in Pluronic P123 micelles.
    Kaur I; Terrazas M; Kosak KM; Kern SE; Boucher KM; Shami PJ
    J Pharm Pharmacol; 2013 Sep; 65(9):1329-36. PubMed ID: 23927471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JS-K as a nitric oxide donor induces apoptosis via the ROS/Ca
    Huang Z; Liu L; Chen J; Cao M; Wang J
    Biomed Pharmacother; 2018 Nov; 107():1385-1392. PubMed ID: 30257354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JS-K, a nitric oxide prodrug, induces cytochrome c release and caspase activation in HL-60 myeloid leukemia cells.
    Udupi V; Yu M; Malaviya S; Saavedra JE; Shami PJ
    Leuk Res; 2006 Oct; 30(10):1279-83. PubMed ID: 16439016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingosine 1-Phosphate Liposomes for Targeted Nitric Oxide Delivery to Mediate Anticancer Effects against Brain Glioma Tumors.
    Liu Y; Wang X; Li J; Tang J; Li B; Zhang Y; Gu N; Yang F
    Adv Mater; 2021 Jul; 33(30):e2101701. PubMed ID: 34106489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JS-K, an arylating nitric oxide (NO) donor, has synergistic anti-leukemic activity with cytarabine (ARA-C).
    Shami PJ; Maciag AE; Eddington JK; Udupi V; Kosak KM; Saavedra JE; Keefer LK
    Leuk Res; 2009 Nov; 33(11):1525-9. PubMed ID: 19193435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JS-K has potent anti-angiogenic activity in vitro and inhibits tumour angiogenesis in a multiple myeloma model in vivo.
    Kiziltepe T; Anderson KC; Kutok JL; Jia L; Boucher KM; Saavedra JE; Keefer LK; Shami PJ
    J Pharm Pharmacol; 2010 Jan; 62(1):145-51. PubMed ID: 20723011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TIMP-2 mediates the anti-invasive effects of the nitric oxide-releasing prodrug JS-K in breast cancer cells.
    Simeone AM; McMurtry V; Nieves-Alicea R; Saavedra JE; Keefer LK; Johnson MM; Tari AM
    Breast Cancer Res; 2008; 10(3):R44. PubMed ID: 18474097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JS-K, a glutathione/glutathione S-transferase-activated nitric oxide releasing prodrug inhibits androgen receptor and WNT-signaling in prostate cancer cells.
    Laschak M; Spindler KD; Schrader AJ; Hessenauer A; Streicher W; Schrader M; Cronauer MV
    BMC Cancer; 2012 Mar; 12():130. PubMed ID: 22462810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A reactive oxygen species activation mechanism contributes to JS-K-induced apoptosis in human bladder cancer cells.
    Qiu M; Chen L; Tan G; Ke L; Zhang S; Chen H; Liu J
    Sci Rep; 2015 Oct; 5():15104. PubMed ID: 26458509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, mechanistic studies, and anti-proliferative activity of glutathione/glutathione S-transferase-activated nitric oxide prodrugs.
    Chakrapani H; Kalathur RC; Maciag AE; Citro ML; Ji X; Keefer LK; Saavedra JE
    Bioorg Med Chem; 2008 Nov; 16(22):9764-71. PubMed ID: 18930407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.